Christine Petzoldt

Challenges in the development of hydrate phases as active pharmaceutical ingredients – An example

Martin P. Feth, N. Nagel, Bruno Baumgartner et al. · European Journal of Pharmaceutical Sciences · 2010 · 28 citations

Pharmacy, Pharmaceutics, Pharmacology +14

An example of how to handle amorphous fractions in API during early pharmaceutical development: SAR114137 – A successful approach

Christine Petzoldt, O. Bley, Stephen J. Byard et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2013 · 16 citations

Pharmacy, Medicinal Chemistry, Pharmaceutics +10

From laboratory to pilot plant: The solid-state process development of a highly potent cathepsin S/K inhibitor

Martin P. Feth, Winfried Heyse, Bruno Baumgartner et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2012 · 13 citations

Life Sciences, Biochemistry, Chemistry +8